Assessment of patient satisfaction, financial, and environmental impacts of teleoncology.

Authors

null

Cindy Jiang

University of Michigan, Ann Arbor, MI

Cindy Jiang, Garth William Strohbehn, Rachel Dedinsky, Shelby Raupp, Brittany Pannecouk, Sarah Elizabeth Yentz, Nithya Ramnath

Organizations

University of Michigan, Ann Arbor, MI, VA Ann Arbor, Ann Arbor, MI, VA Ann Arbor Healthcare System, Ann Arbor, MI, Department of Medical Oncology, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI

Research Funding

No funding received
None

Background: There was rapid adoption of teleoncology at Veterans Health Administration (VHA) during the COVID-19 pandemic. One-third of 9 million VHA-enrolled Veterans live in rural areas. While digital solutions can expand capacity, enhance care access, and reduce financial burden, they may also exacerbate rural-urban health disparities. Careful evaluation of patients’ perceptions and policy tradeoffs are necessary to optimize teleoncology post-pandemic. Methods: Patients with ≥1 teleoncology visit with medical, surgical, or radiation oncology between March 2020 and June 2020 identified retrospectively. Validated, Likert-type survey assessing patient satisfaction developed. Follow-up survey conducted on patients with ≥1 teleoncology visit from August 2020 to January 2021. Travel distance, time, cost, and carbon dioxide (CO2) emissions calculated based on zip codes. Results: 100 surveys completed (response rate, 62%). Table with demographics. Patients overall satisfied with teleoncology (83% ‘Agree’ or ‘Strongly Agree’) but felt less satisfied than in-person visits (47% ‘Agree’ or ‘Strongly Agree’). Audiovisual component improved patient perception of involvement in care (two-sided, p = 0.0254), ability to self-manage health/medical needs (p = 0.0167), and comparability to in person visits (p = 0.0223). Follow-up survey demonstrated similar satisfaction. Total travel-related savings: 86,470 miles, 84,374 minutes, $49,720, and 35.5 metric tons of CO2. Conclusions: Veterans are broadly satisfied with teleoncology. Audiovisual capabilities are critical to satisfaction. This is challenging for rural populations with lack of technology access. Patients experienced financial and time savings, and society benefitted from reduced carbon emissions. Continued optimization needed to enhance patient experience and address secondary effects.

Demographics of eligible and enrolled patients.


Eligible Pts

(n = 366)
Surveyed Pts

(n = 100)
Re-Surveyed Pts

(n = 42)
Age, yrs – Mean (Std. Dev)
68.7 (9.3)
68.6 (8.8)
67.8 (8.3)
Sex

 Female – No. (%)

 Male – No. (%)


16 (4.4)

350 (95.6)
5 (5)

95 (95)


4 (9.5)

38 (90.5)
Race

 White – No. (%)

 Black – No. (%)

 Hawaiian/Pacific Islander – No. (%)

 Did not declare (%)


288 (78.7)

38 (10.4)

6 (1.6)

34 (9.3)


76 (76)

11 (11)

3 (3)

10 (10)


32 (76.2)

5 (11.9)

3 (7.1)

2 (4.8)
Malignancy – No. (%)

 Bladder

 Breast

 CNS

 Endocrine

 Gastrointestinal/hepatobiliary

 Testicular

 Head and neck

 Lung

 Neuroendocrine

 Prostate

 Renal

 Skin and soft tissue


8 (2.2)

10 (2.7)

1 (0.3)

1 (0.3)

110 (30.1)

3 (0.8)

23 (6.3)

82 (22.4)

9 (2.5)

93 (25.4)

6 (1.6)

20 (5.5)


2 (2)

4 (4)

0 (0)

0 (9)

23 (23)

0 (0)

4 (4)

18 (18)

4 (4)

29 (29)

3 (3)

9 (9)


1 (2.4)

2 (4.9)

0 (0)

0 (0)

8 (19)

0 (0)

2 (4.9)

8 (19)

2 (4.9)

15 (35.7)

2 (4.9)

2 (4.9)
Total # Teleoncology Visits
 Visit per pt – Mean (Std. Dev)
560
23076
 Teleoncology Mode

 Audio-Only

 Audiovisual-Only

 Audio + Audiovisual
1.53 (0.92)

n/a
2.3 (1.5)

41 (41.0)

40 (40.0)

19 (19.0)
1.8

11 (26.2)

24 (57.1)

7 (16.7)

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2021 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session B: Patient Experience; Quality, Safety, and Implementation Science; Technology and Innovation in Quality of Care

Track

Technology and Innovation in Quality of Care,Patient Experience,Quality, Safety, and Implementation Science,Cost, Value, and Policy,Health Care Access, Equity, and Disparities

Sub Track

Impact of Telemedicine

Citation

J Clin Oncol 39, 2021 (suppl 28; abstr 278)

DOI

10.1200/JCO.2020.39.28_suppl.278

Abstract #

278

Poster Bd #

Online Only

Abstract Disclosures

Similar Abstracts

Abstract

2023 ASCO Annual Meeting

Rural disparities in telemedicine use among cancer survivors during the COVID-19 pandemic.

First Author: Min Jee Lee

First Author: Sabrina Wilcox

Abstract

2021 ASCO Annual Meeting

Telehealth: Reducing or increasing cancer care disparities?

First Author: Patricia Jewett